166 related articles for article (PubMed ID: 32386192)
1. Circulating tumor cells in whole process management of gastrointestinal stromal tumor in a real-life setting.
Zhang Q; Xu K; Chen M; Miao Y; Wang N; Xu Z; Xu H
Saudi J Gastroenterol; 2020; 26(3):160-167. PubMed ID: 32386192
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of circulating tumor cells and analysis of clinicopathological factors in liver cancer.
Cui K; Ou Y; Ning D; Li H; Xi Y; Li S
J Cancer Res Ther; 2022 Apr; 18(2):452-460. PubMed ID: 35645114
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
[TBL] [Abstract][Full Text] [Related]
5. CD47 Expression in Circulating Tumor Cells and Circulating Tumor Microemboli from Non-Small Cell Lung Cancer Patients Is a Poor Prognosis Factor.
Torres JA; Brito ABC; Silva VSE; Messias IM; Braun AC; Ruano APC; Buim MEC; Carraro DM; Chinen LTD
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569332
[TBL] [Abstract][Full Text] [Related]
6. The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Abdallah EA; Braun AC; Flores BCTCP; Senda L; Urvanegia AC; Calsavara V; Fonseca de Jesus VH; Almeida MFA; Begnami MD; Coimbra FJF; da Costa WL; Nunes DN; Dias-Neto E; Chinen LTD
Oncologist; 2019 Sep; 24(9):e854-e863. PubMed ID: 30846515
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
[TBL] [Abstract][Full Text] [Related]
9. Comparison of CellSearch and Circulating Tumor Cells (CTC)-Biopsy Systems in Detecting Peripheral Blood Circulating Tumor Cells in Patients with Gastric Cancer.
Ning D; Cui K; Liu M; Ou Y; Wang Z; Zou B; Shen Y; Lu X; Li S; Li P
Med Sci Monit; 2021 Jan; 27():e926565. PubMed ID: 33408319
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma.
Bueno de Oliveira T; Camila Braun A; Ribaldo Nicolau U; Ali Abdallah E; da Silva Alves V; Hugo Fonseca de Jesus V; Fernando Calsavara V; Paulo Kowaslki L; Domingos Chinen LT
Oral Oncol; 2021 Oct; 121():105480. PubMed ID: 34403888
[TBL] [Abstract][Full Text] [Related]
11. The rare circulating tumor microemboli as a biomarker contributes to predicting early colorectal cancer recurrences after medical treatment.
Hao YJ; Chang LW; Yang CY; Lo LC; Lin CP; Jian YW; Jiang JK; Tseng FG
Transl Res; 2024 Jan; 263():1-14. PubMed ID: 37558203
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cell Analyses in Patients With Esophageal Squamous Cell Carcinoma Using Epithelial Marker-Dependent and -Independent Approaches.
Li H; Song P; Zou B; Liu M; Cui K; Zhou P; Li S; Zhang B
Medicine (Baltimore); 2015 Sep; 94(38):e1565. PubMed ID: 26402816
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of imatinib trough concentration at steady state in adjuvant therapy of patients with high risk gastrointestinal stromal tumor].
Wan WZ; Zhang P; Zeng XY; Zhou H; Lin Y; Xiong Z; Zhang RZ; Liu WZ; Han Y; Tao KX
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):848-855. PubMed ID: 31550824
[No Abstract] [Full Text] [Related]
15. Clinical Significance of Circulating Tumor Microemboli as a Prognostic Marker in Patients with Pancreatic Ductal Adenocarcinoma.
Chang MC; Chang YT; Chen JY; Jeng YM; Yang CY; Tien YW; Yang SH; Chen HL; Liang TY; Wang CF; Lee EY; Chang YC; Lee WH
Clin Chem; 2016 Mar; 62(3):505-13. PubMed ID: 26861552
[TBL] [Abstract][Full Text] [Related]
16. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
[TBL] [Abstract][Full Text] [Related]
17. The association between circulating tumor cells and Epstein-Barr virus activation in patients with nasopharyngeal carcinoma.
He C; Huang X; Su X; Tang T; Zhang X; Ma J; Guo X; Lv X
Cancer Biol Ther; 2017 Nov; 18(11):888-894. PubMed ID: 28121221
[TBL] [Abstract][Full Text] [Related]
18. [Significance of circulating tumor cell monitoring in targeted therapy for gastrointestinal stromal tumors].
Fan JB; Zhi XF; Chen SS; Zhu JW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):789-795. PubMed ID: 34530560
[No Abstract] [Full Text] [Related]
19. A higher platelet-to-lymphocyte ratio is prevalent in the presence of circulating tumor microemboli and is a potential prognostic factor for non-metastatic colon cancer.
Abdallah EA; Souza E Silva V; Braun AC; Gasparini VA; Kupper BEC; Tariki MS; Tarazona JGR; Takahashi RM; Aguiar Júnior S; Chinen LTD
Transl Oncol; 2021 Jan; 14(1):100932. PubMed ID: 33157516
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma.
Song J; Yu Z; Dong B; Zhu M; Guo X; Ma Y; Zhao S; Yang T
World J Surg Oncol; 2021 May; 19(1):156. PubMed ID: 34034739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
